Land: Australia
Språk: engelsk
Kilde: Department of Health (Therapeutic Goods Administration)
Eptotermin alfa
Stryker Australia Pty Ltd
Medicine Registered
OP-1 IMPLANT 1 OP-1 IMPLANT _eptotermin alfa (rch) _ CONSUMER MEDICINES INFORMATION _ _ WHAT IS IN THIS LEAFLET? This leaflet answers some common questions about OP-1 IMPLANT. It does not contain all the available information. It does not take the place of talking to your doctor. All medicines have benefits and risks. Your doctor has weighed the risks of your treatment with OP-1 IMPLANT against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TREATMENT WITH OP-1 IMPLANT, ASK YOUR DOCTOR. KEEP THIS LEAFLET. You may need to read it again. WHAT OP-1 IMPLANT IS USED FOR OP-1 IMPLANT contains the active ingredient eptotermin alfa (rch). It is used to treat long bone non- union (such as broken arms or legs that have not healed) that were caused by an injury. OP-1 IMPLANT is a powder that is mixed with sterile saline solution ( sodium chloride solution for injection (0.9% w/v) ) to form a paste which is then placed between the broken ends of the bone during surgery. It works by promoting new bone formation. There are many different types of treatments for long bone non- union. Your doctor, however, may have prescribed OP-1 IMPLANT for another purpose. Ask your doctor if you have any questions why OP-1 IMPLANT has been prescribed for you. This medicine is available only with a doctor's prescription. BEFORE YOU ARE GIVEN OP-1 IMPLANT _WHEN YOU MUST NOT BE GIVEN IT _ DO NOT USE OP-1 IMPLANT IF YOU HAVE AN ALLERGY TO: • any medicine containing eptotermin alfa • collagen • any other bone morphogenetic proteins If you are not sure whether this applies to you, check with your doctor DO NOT USE OP-1 IMPLANT IF YOUR ARE PREGNANT. read_full_document
- 1 - PRODUCT INFORMATION - 2 - NAME OF THE MEDICINE Non-proprietary name eptotermin alfa (rch) CAS number 129805-33-0 DESCRIPTION OP-1 IMPLANT is comprised of eptotermin alfa (common name human recombinant bone morphogenetic protein, hrBMP-7 or osteogenic protein-1, OP-1) formulated with bovine collagen. The active form of eptotermin alfa is a dimer comprised of two glycosylated monomers (18 kDa) linked by a disulphide bond. Each vial of OP-1 IMPLANT contains 3.3 mg of eptotermin alfa (sourced from a Chinese Hamster ovary cell line) and 1000 mg bovine collagen (sourced from bovine diaphyseal bone, primarily Type 1) as a lyophilised powder. The powder is to be reconstituted with 2-3 mL sterile Sodium Chloride Solution for Injection (0.9% w/v) prior to use. PHARMACOLOGY _Pharmacological actions _ OP-1 IMPLANT is an osteoinductive and osteoconductive medicinal product. Eptotermin alfa initiates bone formation through the induction of cellular differentiation in mesenchymal cells which are recruited to the implant site from bone marrow, periosteum and muscle. Once bound at the cell surface, eptotermin alfa induces a cascade of cellular events leading to the formation of chondroblasts and osteoblasts which play a key role in the bone formation process. The collagen matrix is insoluble and consists of particles with a size range of 75-425 µm. This provides an appropriate bioresorbable scaffold for the anchorage dependent cell proliferation and differentiation processes induced by eptotermin alfa. The matrix is also osteoconductive and it read_full_document